Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Research into antibiotic-resistant E. coli

Estimates reveal effect of chicken production on humans

Research has revealed that approximately 280 people die every year in the UK as a result of antibiotic-resistant E. coli, acquired from chicken.

The study, carried out by an international team of scientists, looked at the effect of using third-generation cephalosporin – a class of antibiotics – in chicken production.

It is known that the method is causing a rise the number of E. coli cases that are resistant to antibiotics, which is called extended-spectrum beta-lactamase (ESBL) E coli.

The team used Dutch genetic fingerprinting to find a reliable estimate of the number of human blood poisoning infections and deaths caused by ESBL E. coli that have come about as a result of consuming chicken.

They found that chicken production is, according to their analysis, responsible for 1,580 cases of ESBL E. coli blood poisoning every year in the UK.

Furthermore, it was revealed that
each year poultry-associated ESBL E. coli causes an additional 12,500 days in UK hospitals for "last-resort" antibiotic treatment.

"This is the first detailed estimate to emerge of the human-health consequences from the use of antibiotics in European agriculture," said Richard Young, policy adviser at the Soil Association.

"It indicated that large numbers of people die of resistant infections due to the over-reliance on antibiotics in intensive livestock farming."

He added that there are also major additional costs to the NHS from treating patients – even when they survive an ESBL E. coli infection.

Related News
Concerns over resistant E.coli superbugs
Antibiotics a key issue at G8

 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.